GA
OMCL icon

Geneva Advisors’s Omnicell OMCL Stock Holding History

Geneva Advisors’s Portfolio OMCL Stock Details OMCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$2.11M Buy
48,969
+1,763
+4% +$73.2K 0.04% 206
2017
Q1 		$1.92M Buy
47,206
+2,930
+7% +$108K 0.03% 219
2016
Q4 		$1.5M Buy
44,276
+11,881
+37% +$409K 0.03% 259
2016
Q3 		$1.24M Buy
32,395
+1,023
+3% +$38.1K 0.02% 274
2016
Q2 		$1.07M Buy
31,372
+2,100
+7% +$65.5K 0.02% 297
2016
Q1 		$816K Sell
29,272
-1,394
-5% -$38.3K 0.02% 336
2015
Q4 		$953K Buy
+30,666
New +$905K 0.02% 312
2015
Q2 		– Sell
-6,333
Closed -$222K – 708
2015
Q1 		$222K Sell
6,333
-1,309
-17% -$43.2K ﹤0.01% 576
2014
Q4 		$253K Buy
+7,642
New +$236K ﹤0.01% 552

Other funds holding OMCL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
DCM
Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Geneva Advisors's OMCL Position: Q2 2017 in Review

Geneva Advisors increased its Omnicell (OMCL) stake by 3.7% in Q2 2017, buying an estimated $73.2K and bringing the position to 48,969 shares worth $2.11M. The position accounts for 0.04% of the portfolio, ranked #206.

Geneva Advisors first reported a position in OMCL in Q4 2014 and has held it in 9 quarters since. 203 funds tracked by Wall St. Rank hold OMCL as of Q2 2017.

  • Geneva Advisors held 48,969 shares of Omnicell worth $2.11M as of Q2 2017.
  • Geneva Advisors bought 1,763 Omnicell shares in Q2 2017, an estimated $73.2K.
  • Omnicell made up 0.04% of Geneva Advisors's portfolio in Q2 2017, its #206 holding.
  • Geneva Advisors first reported a position in Omnicell in Q4 2014 and has held it in 9 quarters since.
  • 203 funds tracked by Wall St. Rank held Omnicell as of Q2 2017.

Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.